Physician profile
Michaela Lamonde
NPI 1699129817
$1,765.16
in general payments reported to CMS, 2019-2025
21 companies · $1,235 in 2025
The $1,235 reported for 2025 was more than what 92% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $77.64 · 2020: $63.35 · 2023: $78.94 · 2024: $310 · 2025: $1,235.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,238 · Travel and Lodging: $386.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,238.03 |
| Travel and Lodging | $386.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $646.48 | 2024-2025 | |
| Sage Therapeutics, LLC | $241.14 | 2024-2025 | Zurzuvae |
| Organon LLC | $153.18 | 2024-2025 | Nexplanon, Jada System |
| Sumitomo Pharma America, INC. | $99.02 | 2023-2025 | Gemtesa, Myfembree |
| Astellas Pharma US INC | $96.54 | 2024-2025 | Veozah |
| Astrazeneca Pharmaceuticals LP | $77.64 | 2019 | |
| Eisai INC. | $63.35 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $57.65 | 2024-2025 | |
| Novo Nordisk INC | $43.18 | 2024-2025 | Wegovy |
| Exact Sciences Corporation | $34.99 | 2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Millicent US INC | $33.78 | 2025 | Femlyv, Intrarosa |
| Mayne Pharma Commercial LLC | $31.61 | 2025 | |
| Amgen INC. | $30.17 | 2025 | Evenity |
| Daiichi Sankyo INC. | $28.53 | 2023 | Injectafer |
| Axonics, INC. | $20.42 | 2024 | Bulkamid, Axonics |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $20.17 | 2025 | Gardasil 9 |
| Pfizer INC. | $19.96 | 2024 | |
| Ethicon US, LLC | $19.82 | 2025 | Vicryl |
| Coopersurgical, INC. | $17.23 | 2024 | Paragard T 380a |
| Abbvie INC. | $17.08 | 2025 | |
| Hologic Sales and Service, LLC | $13.22 | 2024 | Novasure, Fluent Fluid Management System, Myosure Tissue Removal Device |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michaela Lamonde listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.